Quality improvement and patient safety
Quality improvement and patient safety
Thompson Jeffrey C, Yee Stephanie S, Troxel Andrea B, Savitch Samantha L, Fan Ryan, Balli David, Lieberman David B, Morrissette Jennifer D, Evans Tracey L, Bauml Joshua, Aggarwal Charu, Kosteva John A, Alley Evan, Ciunci Christine, Cohen Roger B, Bagley Stephen, Stonehouse-Lee Susan, Sherry Victoria E, Gilbert Elizabeth, Langer Corey, Vachani Anil, Carpenter Erica L: Detection of therapeutically targetable driver and resistance mutations in lung cancer patients by next generation sequencing of cell-free circulating tumor DNA. Clinical cancer research : an official journal of the American Association for Cancer Research Sep 2016.
Charu Aggarwal, Andrew R Haas, Susan Metzger, Laura K. Aguilar, Estuardo Aguilar-Cordova, Andrea G. Manzanera, Evan W. Alley, Tracey L. Evans, Roger B. Cohen, Joshua Bauml, Corey J. Langer, Steven Albelda, Daniel Sterman: Phase I study of gene mediated cytotoxic immunotherapy (GMCI) for patients with malignant pleural effusion (MPE). J Clin Oncol, presented at ASCO Annual Meeting 34: abstract 3081, June 2016.
Athanassios Argiris, Ju-Whei Lee, James Stevenson, Matthew Gerard Sulecki, Vladimir Hugec, Nicholas W. Choong, Joel N. Saltzman, Wei Song, Richard M. Hansen, Tracey L. Evans, Suresh S. Ramalingam, Joan H. Schiller: E3508: Randomized trial of carboplatin (C), paclitaxel (P), bevacizumab (B) with or without cixutumumab (Cx) in patients (pts) with advanced non-squamous, non-small cell lung cancer (NSCLC). J Clin Oncol, presented at ASCO Annual Meeting 34: abstract 9091, June 2016.
Heather A. Wakelee, Suzanne Eleanor Dahlberg, Steven M. Keller, William J. Tester, David R. Gandara, Stephen L. Graziano, Alex A. Adjei, Natasha B. Leighl, Charles Andrew Butts, Seena C. Aisner, Jan M. Rothman, Jyoti D. Patel, Mark D. Sborov, Raymond S. McDermott, Roman Perez-Soler, Anne M. Traynor, Tracey L. Evans, Leora Horn, Suresh S. Ramalingam, Joan H. Schiller: E1505: Adjuvant chemotherapy +/- bevacizumab for early stage NSCLC—Outcomes based on chemotherapy subsets. J Clin Oncol, presented at ASCO Annual Meeting 34: abstract 8507, June 2016.
Helena Alexandra Yu, Alexander I. Spira, Leora Horn, Jared Weiss, Howard Jack West, Giuseppe Giaccone, Tracey L. Evans, Ronan Joseph Kelly, Bhardwaj B. Desai, Andrew Krivoshik, Tanya E. Fleege, Srinivasu Poondru, Fei Jie, Kouji Aoyama, Debbie Ann Whitcomb, Anne Therese Keating, Geoffrey R. Oxnard: Antitumor activity of ASP8273 300 mg in subjects with EGFR mutation-positive non-small cell lung cancer: Interim results from an ongoing phase 1 study. J Clin Oncol, presented at ASCO Annual Meeting 34: abstract 9050, June 2016.
Maquilan Genevieve, Grover Surbhi, Xanthopoulos Eric, Evans Tracey L, Aggarwal Charu, Langer Corey J, Cohen Roger B, Stevenson James P, Simone Charles B, Rengan Ramesh: Analysis of the Relationship Between Response to Chemotherapy and Response to Radiation Therapy in Patients With Non-Small Cell Lung Cancer Receiving Sequential Treatment. American journal of clinical oncology Apr 2016.
Gabrielle Betty Rocque, Doug Blayney, Mohammad Jahanzeb, Pamela Kadlubek, August Knape, Merry Jennifer Markham, Trang Pham, Tracey L. Evans: Choosing Wisely in oncology: Are we ready for value-based care? J Clin Oncol, presented at ASCO Quality Care Symposium 34(7s): abstract 275, Feb 2016.
Evans Tracey L, Gabriel Peter E, Shulman Lawrence N: Cancer Staging in Electronic Health Records: Strategies to Improve Documentation of These Critical Data. Journal of oncology practice / American Society of Clinical Oncology 12(2): 137-9, Feb 2016.
TL Evans: Chemotherapy in Advanced Non-small Cell Lung Cancer: Optimal Treatment Approach for Elderly and Patients with Poor Performance Status The American Journal of Hematology/Oncology. Devera Pine (eds.). The Coding Institute 11(7): 1-5 July 2015
Brady Anna K, McNeill Jonathan D, Judy Brendan, Bauml Joshua, Evans Tracey L, Cohen Roger B, Langer Corey, Vachani Anil, Aggarwal Charu: Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapy. Oncotarget 6(30): 30287-94, Oct 2015.
back to top
Last updated: 09/26/2016
The Trustees of the University of Pennsylvania